Fashion
-
China Liberal Education Holdings Limited Has Regained Compliance with Nasdaq's Minimum Bid Price DeficiencyDetails
BEIJING,Jan. 13,2025--China Liberal Education Holdings Limited ("China Liberal" or the "Company") (NASDAQ:CLEU),a China-based company that provides technological consulting service
-
Redefining Charging: Anker Innovations Showcases Smart and Sustainable Solutions at CESDetails
BELLEVUE,Wash.,Jan. 13,2025-- Anker Innovations,a global leader in mobile charging and consumer electronics,today unveiled its latest groundbreaking charging innovations at the Consumer Electronics Sh
-
Scintimun® Commercialization Partnership with Curium PharmaDetails
MELBOURNE,Australiaand LIÈGE,Belgium,Jan. 13,2025-- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX,Telix,the Company) today announces that it has entered into an agreement with Curium Ph
-
ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive WorkflowDetails
The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro,extending ZEISS\' LVC market leadership with treatment for myopia,hyperopia,and mixed astigmatism.
-
Gianna Lullume Baby Soother Device Officially Launches on KickstarterDetails
HONG KONG,Jan. 13,2025-- Gianna Lullume,an innovative brand committed to improving infant sleep and promoting family well-being,is proud to announce the official launch of its crowdfunding campaign on
-
Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology PlatformDetails
MELBOURNE,Australiaand INDIANAPOLIS,Jan. 13,2025-- Telix Pharmaceuticals Limited (ASX: TLX,Nasdaq: TLX,Telix,the Company) today announces it has entered into an asset purchase agreement with antibody
-
MLVision M5 Unveiled at CES 2025: Pioneering Innovation in Wearable Technology with the World's Lightest AI-Powered AR GlassesDetails
LAS VEGAS,Jan. 11,2025-- AtCES 2025,MLVision has officially launched its groundbreaking MLVision M5,setting a new global standard for wearable technology. Weighing a mere 25.8 grams,the MLVision M5 is
-
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in OncologyDetails
This is the second asset Menarini Group has inlicensed from Insilico Medicine which was discovered through their generative AI platform,similar to the preclinical stage KAT6 inhibitor (MEN2312) licens
-
Sciwind Biosciences Announces Global Licensing and Collaboration Agreement for Metabolic Disease PortfolioDetails
HANGZHOU,China,Jan. 10,2025--HangzhouSciwind Biosciences Co.,a pre-commercial biopharmaceutical company focusing on developing innovative therapies to treat metabolic diseases,today announced a licens
-
SN BioScience Propels SNB-101 to Phase 2 with IND Clearance from FDADetails
SEOUL,South Korea,Jan. 10,2025-- SNBioScience today announced that its lead asset SNB-101 has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for a